CD14 and breast cancer: Also Safarzadeh et al. (105) showed that M-MDSCs (HLA-DR−CD33+CD14+) represent a high percentage compared with the G-MDSCs (HLA-DR−CD33+CD15+) subpopulation in BC patients.